INFERTILITY DRUGS AND DEVICES MARKET ANALYSIS

Regional Analysis

Global Infertility Drugs and Devices Market- Regional Analysis

Among region, North America is estimated to hold a dominant position in the global infertility drugs and devices market over the forecast period. North America is estimated to hold 42.8% of the market share in 2023. North America infertility drugs and devices market is expected to witness significant growth in the near future, owing to increasing launch by key market players. For instance, in August 2022, Inception Fertility LLC., a tech-enabled company improving patient experience through an ecosystem of fertility brands in U.S., launched HavenCryo, a long-term reproductive preservation and storage solution provider that uses state-of-the-art technologies and enhanced safety protocols to store reproductive tissue, including eggs, sperm, and embryos, for as long as a patient may need. HavenCryo also allows providers to focus on the most critical part of the reproductive journey to patient care as its experienced staff streamlines safe and timely transfers, while its industry-leading technologies enhance the preservation process for patients who are planning for the future.

• North America: U.S. and Canada
• Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
• Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
• Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
• Middle East: GCC Countries, Israel, and Rest of Middle East
• Africa: South Africa, North Africa, and Central Africa